|
New
Harm
Reduction
Grant
Program
for
Activism
and
Policy
By
and
for
Drug
Users
12/3/04
https://stopthedrugwar.org/chronicle-old/365
/ihrd.shtml
The International Harm Reduction
Development Program (IHRD) of the Open Society Institute has announced
a new grant competition in support of activism and policy development by
and for drug users. The competition is open to drug user organizations
in Central and Eastern Europe and Central Asia. Groups may apply
for funding in a two-step process. First, a short Letter of Intent
describing the organization and project concept is due by January 10, 2005.
Selected organizations from the second round will be invited to submit
a full application by February 10, 2005. Applications may be submitted
in either English or Russian. Applications will be reviewed and grants
decided by a committee composed of drug user activists and other advocates.
Since 2001, IHRD has supported
the development of drug user organizations, through direct financial contributions,
technical assistance, and other means. IHRD supports these programs
out of a belief that drug users are their own best advocates, and have
a vital role to play in defining the health, social, legal, and research
policies that affect them. Underlying this assumption is both a basic
commitment to users' rights, and the visible success of user organizations
in Asia, Australia, Eastern and Western Europe and North America in recent
years.
Questions about this program,
or requests for complete details and instructions for applying, including
the Letter of Intent form, may be sent to Matt Curtis at [email protected]
(English), or Dasha Ocheret at [email protected]
or [email protected] (Russian).
Applications should be sent to [email protected].
Visit http://www.soros.org/initiatives/ihrd/
for further information about the International Harm Reduction Development
program.
-- END --
|
Issue #365
, 12/3/04
DRCNet
Event:
Rep.
Barney
Frank
to
Keynote
for
Perry
Fund
Forum/Fundraiser,
December
9,
2004,
Boston
|
DEA
Retraction
of
Pain
FAQ
Angers,
Scares
Doctors
and
Patients
|
Hurwitz
Trial
Update
and
Call
for
Support
|
Raich
Case
as
Much
About
Federalism
as
About
Medical
Marijuana
|
Medical
Marijuana
at
the
Supreme
Court
--
a
Taste
of
the
Day's
Events
|
Top
Cops
Say
Drug
War
a
Flop
in
Two
New
Surveys
|
Newsbrief:
Group
Can
Display
Marijuana
Reform
Ads,
Federal
Court
Rules
|
Newsbrief:
Supreme
Court
Puts
Hold
on
Religious
Ayahuasca
Use
|
Newsbrief:
Delaware
Legislature
to
Take
Up
Needle
Exchange
Again
|
Newsbrief:
Britain's
Brave
New
World
of
Drug
Testing
Gets
Underway
|
Newsbrief:
Afghan
Opium
Farmers
Claim
They
Are
Being
Sprayed
With
Pesticides
|
Newsbrief:
Drug
Policy
Alliance
Rejects
Grant
Over
Anti-Terror
Clause
|
Newsbrief:
Federal
Sentencing
Guidelines
Fill
Prisons
With
Blacks,
Hispanics,
Study
Finds
|
This
Week's
Corrupt
Cops
Story
|
This
Week
in
History
|
New
Harm
Reduction
Grant
Program
for
Activism
and
Policy
By
and
for
Drug
Users
|
Apply
Now
to
Intern
at
DRCNet!
|
Drugwarmarket.Com
Seeking
Information,
Affiliations,
Link
Exchanges
|
The
Reformer's
Calendar
|
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
|
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail [email protected]. Thank
you.
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.
|
